Research Article
Inhibitory Effect of Herbal Remedy PERVIVO and Anti-Inflammatory Drug Sulindac on L-1 Sarcoma Tumor Growth and Tumor Angiogenesis in Balb/c Mice
Table 4
Statistical analysis of the results presented in Figure
4.
(a) |
| One-way analysis of variance |
| value | <0.0001 | value summary | **** | Are means. signif. different? ( < 0.05) | Yes | Number of groups | 4 | | 14.42 | square | 0.3223 |
|
|
(b) |
| Bonferroni test | Mean diff. | | Significant? | < 0.05? |
| Control versus sulindac | 4.890 | 6.973 | Yes | *** | Control versus PERVIVO | 2.430 | 3.465 | No | ns. | Control versus sulindac + PERVIVO | 4.530 | 8.125 | Yes | *** | Sulindac versus PERVIVO | −2.460 | 2.892 | No | ns. | Sulindac versus sulindac + PERVIVO | −0.3600 | 0.4886 | No | ns. | PERVIVO versus sulindac + PERVIVO | 2.100 | 2.850 | No | ns. | Sulindac versus sulindac + PERVIVO | −0.3600 | 0.4886 | No | ns. | PERVIVO versus sulindac + PERVIVO | 2.100 | 2.850 | No | ns. |
|
|
, ****.
|